Yes, Some Vaccines Contain Aluminum. That’s a Good Thing.
R.F.K. Jr. and others have blamed the ingredient for allergies and other illnesses. Scientists say it actually bolsters the immune response.
New Research Finds Potential Alternative to Abortion Pill Mifepristone
The research could further complicate the polarized politics of abortion because the drug in the study is the key ingredient in a pill used for emergency contraception.
Man Charged With Giving Fake Botox Injections That Sickened Clients
A Manhattan aesthetician was arrested and charged with injecting patients at his medical spa with counterfeit Botox, prosecutors said, sending some to the hospital.
If You’re Retired, or Not: 5 Changes That Will Affect Your Money in 2025
This year, older workers will have ways to save more for retirement, spend less on medicine and see other ways to improve their finances.
RFK Jr. Sought to Stop Covid Vaccinations 6 Months After Rollout
Robert F. Kennedy Jr. petitioned the F.D.A. to revoke authorization of the shots at a time when they were in high demand and considered life-saving.
Medicare to Negotiate Lower Prices for Weight-Loss Drugs
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.
Ramaswamy Has a High-Profile Perch and a Raft of Potential Conflicts
Vivek Ramaswamy, Elon Musk’s partner in an effort to cut government costs, could make decisions that ultimately make him and his investors richer.
Insulin Prices Dropped. But Some Poor Patients Are Paying More.
A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for low-income health clinics.
FDA Bans Red Dye 3 in Foods, Linking It to Cancer in Rats
Consumer and food safety groups have long urged the agency to revoke the use of this dye and others. The F.D.A. says there still is no evidence it is a human carcinogenic.
How a Company Makes Millions Off a Hospital Program Meant to Help the Poor
A private business has helped supercharge a controversial federal drug program. Patients and insurers have been left with big bills.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.